Drugs / Rett-T
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT04041713 Comparator | Oct 2025 → Nov 2026 expected | Rett syndrome | Holland Bloorview Kids Rehabilitation Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Rett-T | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04041713 ↗ |
| Route | Oral | “Rett T is a powder for oral suspension.” NCT04041713 ↗ |